Literature DB >> 28086224

Asthma and the risk of lung cancer: a meta-analysis.

Yan-Liang Qu1, Jun Liu2, Li-Xin Zhang1, Chun-Min Wu1, Ai-Jie Chu1, Bao-Lei Wen1, Chao Ma1, Xu-Yan Yan1, Xin Zhang1, De-Ming Wang1, Xin Lv2, Shu-Jian Hou3.   

Abstract

Some studies found that there was a significant association between asthma and the risk of lung cancer. However, the results are inconclusive. Therefore, we performed a meta-analysis. We searched the electronic databases for all relevant articles. Odds ratio (OR) with 95% confidence interval (CI) were used to calculate the strength of the association between asthma and lung cancer risk. Asthma was significantly associated with the increased risk of lung cancer (OR = 1.44; 95% CI 1.31-1.59; P < 0.00001; I2 = 83%). Additionally, asthma patients without smoking also had the increased lung cancer risk. In the subgroup analysis of race and gender, Caucasians, Asians, male, and female patients with asthma showed the increased risk of lung cancer. However, asthma was not significantly associated with lung adenocarcinoma risk. In the stratified analysis by asthma definition, significant associations were found between asthma and lung cancer in self-reported subgroup, questionnaire subgroup, and register databases subgroup. However, no significant association was observed in physician-diagnosed asthma subgroup. In conclusion, this meta-analysis suggested that asthma might be significantly associated with lung cancer risk.

Entities:  

Keywords:  association; asthma; lung cancer; meta-analysis

Mesh:

Year:  2017        PMID: 28086224      PMCID: PMC5355290          DOI: 10.18632/oncotarget.14595

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


INTRODUCTION

Lung cancer is one of the most common malignant tumors affecting millions of people around the world. It is acknowledged that smoking is the most important risk factor of lung cancer [1]. Sun et al. suggested that approximately 25% of lung cancer cases worldwide are not attributable to tobacco use [2]. This fact indicated that other factors might contribute to susceptibility to lung cancer. Asthma is one of the most common diseases of childhood, with an estimated global prevalence of 10% among children aged 6–7 [3]. It is a condition characterized by chronic inflammation of the lungs, presenting with airway hyper-reactivity, excessive mucous formation, and respiratory obstruction. The chronic inflammation had an important role in the cancer development [4]. Thus, the chronic inflammation in conditions such as asthma might lead to lung cancer development. Some studies found that there was a significant association between asthma and the risk of lung cancer. However, the results are inconclusive [5-22]. Therefore, we performed a meta-analysis to determine the association between asthma and lung cancer risk.

RESULTS

Characteristics of eligible studies

The detailed literature search strategy was showed in Figure 1. A total of 884 potential studies were identified by preliminary searching. After carefully review, 18 studies were included in this meta-analysis [5-22]. Four studies reported two independent studies. Thus, 22 studies with 16375202 subjects were included. Table 1 presents the main characteristics of these studies, such as first author's name, year of publication, ethnicity, gender, age, asthma definition, lung cancer definition, duration of follow-up, sample size, and adjustment. The quality of the studies was high.
Figure 1

The selection of included studies

Table 1

Characteristics of the included studies

First authorYearRaceGenderAge (y)Definition of asthmaDefinition of lung cancerFollow-up yearsSamle sizeCovariantsNOS
Alderson1974MixedMixed25–59Self-reportedObtain from register databases211892No7
Reynolds 11987MixedMaleNASelf-reportedObtain from register databases183117Age, smoking9
Reynolds 21987MixedFemaleNASelf-reportedObtain from register databases183708Age, smoking9
Mills1992CaucasianMixedNAQuestionnaireMailed questionnaires and tumor registries634198Age, sex, smoking history, and time since last physician contact9
Vesterinen1993CaucasianMixedNAObtain from register databasesObtain from register databases735126No7
Eriksson1995CaucasianMixed16–79Physician-diagnosedObtain from register databases146593No7
Huovinen1997CaucasianMale> 18Self-reportedObtain from register databases1614654Age, smoking, social class, pets, dogs, chronic bronchitis, dyspnoea, hay fever9
Boffetta 12002CaucasianMale> 20Obtain from register databasesObtain from register databases8.542663Duration of follow-up, calendar year at entry, age, other diagnoses, emphysema, chronic bronchitis9
Boffetta 22002CaucasianFemale> 20Obtain from register databasesObtain from register databases8.550323Duration of follow-up, calendar year at entry, age, other diagnoses, emphysema, chronic bronchitis9
Talbot-Smith 12003CaucasianMaleNAPhysician-diagnosedObtain from register databases19124Age, smoking8
Talbot-Smith 22003CaucasianFemaleNAPhysician-diagnosedObtain from register databases19155Age, smoking8
Vandentorren2003MixedMixed25–59QuestionnaireObtain from register databases2514286Age, sex, educational level, smoking habit, occupational exposure and forced expiratory volume in one second9
Littman2004MixedMixed44–74Self-reportedObtain from register databases9.117698Sex, exposure cohort, study arm, education, body mass index, years smoked and years smoked squared, average number of cigarettes smoked per day and average number of cigarettes smoked per day squared, and all other lung diseases, and stratified by smoking status9
Turner2005MixedMixed> 30Self-reportedObtain from register databases1926097Age, gender, race, smoking, education, marital status, body mass index, occupational exposures, beer, wine, and liquor consumption, chronic bronchitis, emphysema, tuberculosis, intakes of vegetables, fruit, fiber, and fat, and passive smoking9
Brown2006MixedMixed50–89Self-reportedSelf-reported98896Age, smoking, sociodemographics8
Gonzalez-Perez2006MixedMixed20–79Self-reportedMailed questionnaires718792Age, sex, calendar year, body mass index, alcohol intake, smoking status, prior comorbidities, health services utilization, use of aspirin, and paracetamol8
Ji2009MixedMixedNAObtain from register databasesObtain from register databases40140425No7
Colak2015MixedMixed56Self-reportedObtain from register databases9.494097Age, sex, body mass index, familial pre-disposition for asthma, allergy, childhood asthma, hay fever, or eczema, use of asthma medication, occupational exposure to dust and/or fumes, daily exposure to passive smoking, physical activity in leisure-time, education, annual household income, and cumulative tobacco consumption8
Huang 12015AsianMale> 20Obtain from register databasesObtain from register databases48002536Lung diseases, low income, age, comorbidities, urbanization and geographic area9
Huang 22015AsianFemale> 20Obtain from register databasesObtain from register databases47216488Lung diseases, low income, age, comorbidities, urbanization and geographic area9
Fan2016AsianMixed40–9Physician-diagnosedChest radiography, physician-diagnosed, obtain from register databases99295Age, sex, education, smoking, arsenic level, radon level, prior comorbidities8
Pirie2016MixedFemale56QuestionnaireObtain from register databases14634039Age, region, deprivation quintile, height7

NA, not available.

NA, not available.

Association of asthma and risk of lung cancer

As shown in Figure 2, asthma was significantly associated with the increased risk of lung cancer (odds ratio (OR) = 1.44; 95% confidence interval (CI) 1.31–1.59; P < 0.00001; I2 = 83%). Additionally, asthma patients without smoking also had the increased lung cancer risk (OR = 1.28; 95% CI 1.10–1.50; P = 0.002; I2 = 0%). In the subgroup analysis of race, both Caucasians and Asians with asthma showed the same results (OR = 1.53; 95% CI 1.37–1.72; P < 0.00001; I2 = 56%; OR = 1.52; 95% CI 1.15–2.01; P < 0.00001; I2 = 93%). In the stratified analysis by gender, both male and female patients with asthma showed the increased risk of lung cancer (OR = 1.38; 95% CI 1.31–1.46; P < 0.00001; I2 = 24%; OR = 1.68; 95% CI 1.45–1.95; P < 0.00001; I2 = 63%). However, asthma was not significantly associated with lung adenocarcinoma risk (OR = 1.01; 95% CI 0.69–1.50; P = 0.95; I2 = 45%). In the stratified analysis by asthma definition, significant associations were found between asthma and lung cancer in self-reported subgroup (OR = 1.23; 95% CI 1.03–1.48; P = 0.02; I2 = 53%), questionnaire subgroup (OR = 1.32; 95% CI 1.12–1.57; P = 0.001; I2 = 0%), and register databases subgroup (OR = 1.60; 95% CI 1.42–1.79; P < 0.00001; I2 = 91%). However, no significant association was observed in physician-diagnosed asthma subgroup (OR = 1.26; 95% CI 0.96–1.65; P = 0.10; I2 = 0%). The results were showed in Table 2.
Figure 2

Meta-analysis of the association between asthma and lung cancer

Table 2

Results of this meta-analysis

No. of studyOR (95% CI)P Value for meta-analysisI2 (%)P Value for subgroup analysis
Overall lung cancer risk231.44 (1.31–1.59)< 0.0000183
Non-smoker41.28 (1.10–.50)0.0020
Subgroup analysis
Race0.95
 Caucasian91.53 (1.37–1.72)< 0.0000156
 Asian31.52 (1.15–2.01)< 0.0000193
Gender0.02
 Male61.38 (1.31–1.46)< 0.0000124
 Female61.68 (1.45–1.95)< 0.0000163
Lung adenocarcinoma21.01 (0.69–1.50)0.9545
Definition of asthma0.05
 Self-reported91.23 (1.03–1.48)0.0253
 Questionnaire31.32 (1.12–1.57)0.0010
 Physician-diagnosed41.26 (0.96–1.65)0.100
 Register databases71.60 (1.42–1.79)< 0.0000191
In the sensitive analysis, similar data were observed after sequentially excluding each study (Figure 3). Furthermore, when the studies without adjustment were excluded, the result was still statistically significant (OR = 1.43, 95% CI 1.28–1.60, P < 0.00001; I2 = 80%). In addition, after excluding the studies without adjusting smoking and age, the result was not changed (OR = 1.29, 95% CI 1.12–1.48, P = 0.0004; I2 = 27%). The results were showed in Table 3.
Figure 3

Sensitivity analysis of the association between asthma and lung cancer

Table 3

Results of sensitivity analysis

No. of studyOR (95% CI)P ValueI2 (%)
Studies with adjustment181.43 (1.28–1.60)< 0.0000180
Adjustment with smoking and age121.29 (1.12–1.48)0.000427
The publication bias of the included studies was assessed by the funnel plot and Egger's test. The funnel plot was symmetric (Figure 4). Egger's test showed no significant publication bias (P = 0.683).
Figure 4

Funnel plot of the association between asthma and lung cancer

DISCUSSION

This present meta-analysis investigating the relationship between asthma and lung cancer risk. Eighteen studies with a total of 16375202 individuals were included in this meta-analysis. Prior asthma was significantly associated with lung cancer risk. In the subgroup analysis of race, both Caucasians and Asians with asthma showed the same results. In the stratified analysis by gender, both male and female patients with asthma showed the increased risk of lung cancer. Smoke habit was a recognized risk factor for lung cancer. However, asthma patients without smoking also had the increased lung cancer risk. These results suggested that asthma might be an independent risk factor for lung cancer. Lung cancer is classified small cell lung cancer and adenocarcinoma, squamous cell carcinoma, and large cell carcinoma [23]. Asthma was not significantly associated with lung adenocarcinoma risk in this meta-analysis. Future studies should be performed to assess the association between asthma and other pathological types of lung cancer. In the stratified analysis by asthma definition, significant associations were found in self-reported subgroup, questionnaire subgroup, and register databases subgroup. However, no significant association was observed in physician-diagnosed asthma subgroup. Only four studies were included in this subgroup. A positive association could therefore not be ruled out, because studies with small sample sizes may have had insufficient statistical power to detect any slight effect. To determine the stability of the result, we did sensitivity analysis. Removal of each study did not change the result, suggesting the reliability of our result. The adjusted ORs could be used to overcome some of the confounding within the observational studies. Thus, we did sensitivity analysis by excluding the studies without adjustment. The result was still statistically significant. Asthma is a disease of chronic airway inflammation characterized by recurrent episodes of wheezing, dyspnea, chest tightness, and cough. Inflammatory cell types, such as T and B lymphocytes, mast cells, eosinophils, basophils, neutrophils and dendritic cells, as well as structural cell types including epithelial and mesenchymal cells involved in airway inflammation [24]. Inflammation also plays a pivotal role in the pathogenesis of lung cancer. Ballaz and Mulshine indicated that chronic inflammation contributes to the process of lung carcinogenesis [25]. Azad et al. suggested that chronic inflammation-induced production of reactive oxygen/nitrogen species in the lung may predispose individuals to lung cancer [26]. This meta-analysis was stable and reliable. First, sensitivity analyses revealed that the results were robust. Second, no significant publication bias was found in this meta-analysis. Third, the sample size of this meta-analysis was large enough. Several limitations should be noted. First, other races, such as African, were not included. Second, heterogeneity was high in this meta-analysis. Third, subgroup analysis based on study level variables could be due to the potential for ecological fallacy. Therefore, more studies are required to confirm the results of this meta-analysis. In conclusion, this meta-analysis suggested that asthma might be significantly associated with lung cancer risk.

MATERIALS AND METHODS

Publication search

Two authors (YLQ and JL) searched Pubmed, Embase, Chinese National Knowledge Infrastructure (CNKI) and Wanfang databases (www.wanfangdata.com.cn). We also checked American Society of Clinical Oncology (ASCO) meeting abstracts to find grey literature (http://meetinglibrary.asco.org/abstracts). Last search was updated in 10 Nov, 2016. We searched the bibliographies of identified studies and narrative reviews for additional citations. No language and time restriction were imposed in this meta-analysis. The detailed search strategy is showed in the Supplementary Material.

Study selection

Two authors (YLQ and JL) searched the titles and abstracts obtained from the initial electronic search for potentially relevant studies for full review. Two authors (YLQ and LXZ) then assessed the full text of the retrieved studies to determine whether the study met the inclusion criteria. Studies included in this meta-analysis should meet the following criteria: (1) study design: prospective cohort study, cross-sectional study, and longitudinal study; (2) population: individuals without lung cancer; (3) exposure: asthma or wheeze; (4) comparison: individuals without asthma or wheeze; (5) outcome: relative risk (RR), hazard ratio (HR), or OR with corresponding 95% CI of lung cancer risk in overall population and in non-smokers. If serial studies of the same population from the same group were reported, the largest study was included. Reviews, meta-analyses, letters, and editorial articles were all excluded. We resolved disagreement by consensus.

Data extraction and qualitative assessment

Two investigators (YLQ and JL) extracted the data independently. The following data were collected from each study: first author's name, year of publication, ethnicity, gender, age, asthma definition, lung cancer definition, duration of follow-up, sample size, and adjustment. The Newcastle–Ottawa Scale (NOS) was used to assess the quality of included studies.

Statistical analysis

ORs with 95% CIs were used to calculate the strength of the association between asthma and lung cancer risk. Random effects model was used in this meta-analysis. Heterogeneity among studies was examined with I2 statistic and Q statistic. Subgroup analysis was carried out by smoke status, ethnicity, gender, subtype of lung cancer, and definition of asthma. Relative influence of each study on the pooled estimate was assessed by omitting one study at a time for sensitivity analysis. Sensitivity analysis was also performed by excluding studies without adjustment, studies without adjustment of age and smoking. Funnel plot and Begg's test were employed to evaluate publication bias. All statistical tests were performed using the STATA 11.0 software (Stata Corporation, College Station, TX). A P value < 0.05 was considered statistically significant, except for tests of heterogeneity where a level of 0.10 was used. All tests were two-sided.
  26 in total

1.  Genome-wide search for atopy susceptibility genes in Dutch families with asthma.

Authors:  Gerard H Koppelman; O Colin Stine; Jianfeng Xu; Timothy D Howard; Siqun L Zheng; Henk F Kauffman; Eugene R Bleecker; Deborah A Meyers; Dirkje S Postma
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

2.  Mortality of adults with asthma: a prospective cohort study.

Authors:  E Huovinen; J Kaprio; E Vesterinen; M Koskenvuo
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

Review 3.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

4.  Asthma and cancer.

Authors:  P Reynolds; G A Kaplan
Journal:  Am J Epidemiol       Date:  1987-03       Impact factor: 4.897

5.  A prospective study of cancer incidence in a cohort examined for allergy.

Authors:  N E Eriksson; A Holmén; B Högstedt; Z Mikoczy; L Hagmar
Journal:  Allergy       Date:  1995-09       Impact factor: 13.146

6.  Cancer incidence in a general population of asthma patients.

Authors:  Antonio González-Pérez; Carlos Fernández-Vidaurre; Ana Rueda; Elena Rivero; Luis A García Rodríguez
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-02       Impact factor: 2.890

7.  Long-term mortality among adults with or without asthma in the PAARC study.

Authors:  S Vandentorren; I Baldi; I Annesi Maesano; D Charpin; F Neukirch; L Filleul; A Cantagrel; J F Tessier
Journal:  Eur Respir J       Date:  2003-03       Impact factor: 16.671

8.  Re: asthma and the risk of lung cancer. findings from the Adverse Childhood Experiences (ACE).

Authors:  David W Brown; Karen E Young; Robert F Anda; Vincent J Felitti; Wayne H Giles
Journal:  Cancer Causes Control       Date:  2006-04       Impact factor: 2.506

9.  Cancer incidence among 78,000 asthmatic patients.

Authors:  E Vesterinen; E Pukkala; T Timonen; A Aromaa
Journal:  Int J Epidemiol       Date:  1993-12       Impact factor: 7.196

10.  Modification of association between prior lung disease and lung cancer by inhaled arsenic: A prospective occupational-based cohort study in Yunnan, China.

Authors:  Yaguang Fan; Yong Jiang; Ping Hu; Runsheng Chang; Shuxiang Yao; Bin Wang; Xuebing Li; Qinghua Zhou; Youlin Qiao
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-04-13       Impact factor: 5.563

View more
  19 in total

1.  Dietary quality using four dietary indices and lung cancer risk: the Golestan Cohort Study (GCS).

Authors:  Qian Wang; Maryam Hashemian; Sadaf G Sepanlou; Maryam Sharafkhah; Hossein Poustchi; Masoud Khoshnia; Abdolsamad Gharavi; Akram Pourshams; Akbar Fazeltabar Malekshah; Farin Kamangar; Arash Etemadi; Christian C Abnet; Sanford M Dawsey; Reza Malekzadeh; Paolo Boffetta
Journal:  Cancer Causes Control       Date:  2021-02-21       Impact factor: 2.506

2.  Using residential histories in case-control analysis of lung cancer and mountaintop removal coal mining in Central Appalachia.

Authors:  W J Christian; C J Walker; B Huang; J E Levy; E Durbin; S Arnold
Journal:  Spat Spatiotemporal Epidemiol       Date:  2020-07-24

3.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

4.  Allergies and Asthma in Relation to Cancer Risk.

Authors:  Elizabeth D Kantor; Meier Hsu; Mengmeng Du; Lisa B Signorello
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-05       Impact factor: 4.254

5.  Invasive bronchial fibroblasts derived from asthmatic patients activate lung cancer A549 cells in vitro.

Authors:  Damian Ryszawy; Filip Rolski; Karolina Ryczek; Jessica Catapano; Tomasz Wróbel; Marta Michalik; Jarosław Czyż
Journal:  Oncol Lett       Date:  2018-09-19       Impact factor: 2.967

6.  Incidence, Progression, and Patterns of Multimorbidity in Community-Dwelling Middle-Aged Men and Women.

Authors:  Xianwen Shang; Wei Peng; Edward Hill; Cassandra Szoeke; Mingguang He; Lei Zhang
Journal:  Front Public Health       Date:  2020-08-18

7.  Erectile Dysfunction After Surgical Treatment of Lung Cancer: Real-World Evidence.

Authors:  Ming-Szu Hung; Yi-Chuan Chen; Tsung-Yu Huang; Dong-Ru Ho; Chuan-Pin Lee; Pau-Chung Chen; Yao-Hsu Yang
Journal:  Clin Epidemiol       Date:  2020-09-11       Impact factor: 4.790

8.  A network-based approach to uncover microRNA-mediated disease comorbidities and potential pathobiological implications.

Authors:  Shuting Jin; Xiangxiang Zeng; Jiansong Fang; Jiawei Lin; Stephen Y Chan; Serpil C Erzurum; Feixiong Cheng
Journal:  NPJ Syst Biol Appl       Date:  2019-11-13

9.  Blood test shows high accuracy in detecting stage I non-small cell lung cancer.

Authors:  Cherylle Goebel; Christopher L Louden; Robert Mckenna; Osita Onugha; Andrew Wachtel; Thomas Long
Journal:  BMC Cancer       Date:  2020-02-21       Impact factor: 4.430

Review 10.  Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab.

Authors:  David J Jackson; Stephanie Korn; Sameer K Mathur; Peter Barker; Venkata G Meka; Ubaldo J Martin; James G Zangrilli
Journal:  Drug Saf       Date:  2020-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.